These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2837869)

  • 1. [Somatomedin activity in patients with malignant neoplasms].
    Vasil'eva IA; Dil'man VM
    Vopr Onkol; 1988; 34(5):531-4. PubMed ID: 2837869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Somatomedin activity of the blood: hormonal metabolic and immunological shifts in cancer patients].
    Vasil'eva IA; Kovalenko IG; Gamaiunova VB; Poroshina TE; Dil'man VM
    Vopr Onkol; 1988; 34(8):926-31. PubMed ID: 3047978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of dyslipidemia in cancer patients].
    Ostroumova MN; Kovalenko IG; Bershteĭn LM; Tsyrlina EV; Dil'man VM
    Vopr Onkol; 1986; 32(1):34-43. PubMed ID: 3946086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of phenformin and miscleron on the blood somatomedin activity level in breast cancer].
    Vasil'eva IA; Bershteĭn LM; Ostroumova MN; Dil'man VM
    Vopr Onkol; 1980; 26(9):34-6. PubMed ID: 7423902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelation between lipidemia and somatomedin activity in cancer and age-associated pathology.
    Vasileva IA; Ostroumova MN; Dilman VM
    Neoplasma; 1982; 29(4):469-75. PubMed ID: 7133238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gc group distributions in patients with cancer.
    Hughes NR
    J Natl Cancer Inst; 1968 Aug; 41(2):303-11. PubMed ID: 4299536
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dexamethasone test, somatomedin level and other metabolic indices in adenoma and cancer of the prostate].
    Portnoĭ AS; Ostroumova MN; Vacil'eva IA; Dil'man VM
    Vopr Onkol; 1983; 29(1):34-9. PubMed ID: 6186084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of natural killer cell activity by serum from cancer patients: preliminary results of a study of patients with colorectal adenocarcinoma or other types of cancer.
    Pislarasu M; Oproiu A; Taranu D; Herberman RB; Sulica A
    Cancer Res; 1988 May; 48(9):2596-603. PubMed ID: 3356020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary-multiple malignant tumors of the colon, uterus and breast].
    Rybin EP; Mosidze BA; Nemsadze GG
    Vopr Onkol; 1986; 32(9):43-7. PubMed ID: 3765522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum chromogranin A is detectable in patients with carcinomas at advanced disease stages.
    Wu JT; Erickson AJ; Tsao KC; Wu TL; Sun CF
    Ann Clin Lab Sci; 2000 Apr; 30(2):175-8. PubMed ID: 10807161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and cancer. A review of epidemiological studies on the relationship of obesity to cancer of the colon, rectum, prostate, breast, ovaries, and endometrium.
    Osler M
    Dan Med Bull; 1987 Oct; 34(5):267-74. PubMed ID: 3315476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate specific antigen (PSA) in breast and ovarian cancer.
    Kucera E; Kainz C; Tempfer C; Zeillinger R; Koelbl H; Sliutz G
    Anticancer Res; 1997; 17(6D):4735-7. PubMed ID: 9494598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudouridine determination in blood serum as tumor marker.
    Salvatore F; Russo T; Colonna A; Cimino L; Mazzacca G; Cimino F
    Cancer Detect Prev; 1983; 6(6):531-6. PubMed ID: 6318996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin III profiles in malignancy, relationship primary tumors and metastatic sites.
    Honegger H; Anderson N; Hewitt LA; Tullis JL
    Thromb Haemost; 1981 Aug; 46(2):500-3. PubMed ID: 7302888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
    Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991.
    McCredie M; Macfarlane GJ; Bell J; Coates M
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):155-60. PubMed ID: 9138657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma thrombomodulin in cancer patients.
    Lindahl AK; Boffa MC; Abildgaard U
    Thromb Haemost; 1993 Feb; 69(2):112-4. PubMed ID: 8384380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human tumor growth in nude mice is associated with decreased plasma cysteine and homocysteine.
    Al-Awadi F; Yang M; Tan Y; Han Q; Li S; Hoffman RM
    Anticancer Res; 2008; 28(5A):2541-4. PubMed ID: 19035276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of serum tumor markers in patients with carcinoma of the ovary.
    Kikuchi Y; Kizawa I; Koyama E; Kato K
    Obstet Gynecol; 1984 Apr; 63(4):561-6. PubMed ID: 6199705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum level of sialyl Lewis(x) antigen in blood from the tumor drainage vein in patients with non-polypoid growth type of colorectal cancer.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Ohbatake M; Nanashima A; Yamaguchi H; Kurosaki N; Yasutake T; Ayabe H; Arisawa K
    J Exp Clin Cancer Res; 2001 Mar; 20(1):85-90. PubMed ID: 11370835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.